Clinical trial

Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics

NCT01503892

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-12-01

PhaseNA

Study timeline

Study start (unknown)2011-12-01Date precision: month

Registry last updated2012-07-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Peripheral Neuropathyunresolved

Interventions

MetanxDIETARY_SUPPLEMENT

PlaceboDRUG

Sponsors & collaborators

St. Luke's Hospital and Health Network, Pennsylvanialead sponsor

Goldfarb Foundationcollaborator

Pamlab, L.L.C.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01503892 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.